In this case, the patient was receiving levetiracetam (Keppra, 1000 mg × 2) for seizure control and methylprednisolone (1 × 2 per os) for RA management but was not on TNF or IL-6 inhibitors, which may have contributed to continued amyloid deposition and disease progression. This evidence concerns the gene IL6 and rheumatoid arthritis.